BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 16970014)

  • 1. [Myositis as a 'radiation-recall phenomenon' following palliative chemotherapy with carboplatin-gemcitabin for non-small-cell pulmonary carcinoma].
    Pinson PJ; Griep C; Sanders WH; Lelie B
    Ned Tijdschr Geneeskd; 2006 Aug; 150(34):1891-4. PubMed ID: 16970014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Two cases of radiation myositis probably induced by recall phenomenon].
    Miura G; Matsumoto T; Tanaka N; Emoto T; Kawamura T; Matsunaga N
    Nihon Igaku Hoshasen Gakkai Zasshi; 2003 Sep; 63(8):420-2. PubMed ID: 14587415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiation recall reaction following gemcitabine.
    Fogarty G; Ball D; Rischin D
    Lung Cancer; 2001; 33(2-3):299-302. PubMed ID: 11551425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High frequency of radiation pneumonitis in patients with locally advanced non-small cell lung cancer treated with concurrent radiotherapy and gemcitabine after induction with gemcitabine and carboplatin.
    Arrieta O; Gallardo-Rincón D; Villarreal-Garza C; Michel RM; Astorga-Ramos AM; Martínez-Barrera L; de la Garza J
    J Thorac Oncol; 2009 Jul; 4(7):845-52. PubMed ID: 19487963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gemcitabine-induced rectus abdominus radiation recall.
    Fakih MG
    JOP; 2006 May; 7(3):306-10. PubMed ID: 16685112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An unusual case of gemcitabine-induced radiation recall.
    Squire S; Chan M; Feller E; Mega A; Gold R
    Am J Clin Oncol; 2006 Dec; 29(6):636. PubMed ID: 17149004
    [No Abstract]   [Full Text] [Related]  

  • 7. Radiation recall myositis: two sites, one patient.
    Grover S; Jones JA; Teitelbaum U; Apisarnthanarax S
    Pract Radiat Oncol; 2015; 5(1):39-42. PubMed ID: 25413426
    [No Abstract]   [Full Text] [Related]  

  • 8. Pectoralis major radiation recall.
    Hack E; Thachil T; Karanth N
    J Med Radiat Sci; 2019 Mar; 66(1):62-65. PubMed ID: 30198200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A phase I/II trial of induction chemotherapy with carboplatin and gemcitabine followed by concurrent vinorelbine and paclitaxel with chest radiation in patients with stage III non-small cell lung cancer.
    Argiris A; Liptay M; LaCombe M; Marymont M; Kies MS; Sundaresan S; Masters G
    Lung Cancer; 2004 Aug; 45(2):243-53. PubMed ID: 15246197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gemcitabine-induced radiation recall dermatitis: case report.
    Bar-Sela G; Beny A; Bergman R; Kuten A
    Tumori; 2001; 87(6):428-30. PubMed ID: 11989599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. "The best-laid plans ... often go awry ...".
    Urbanic JJ; Lally B; Blackstock AW
    J Thorac Oncol; 2009 Jul; 4(7):783-4. PubMed ID: 19550240
    [No Abstract]   [Full Text] [Related]  

  • 12. [Concomitant radiochemotherapy for non-small-cell lung cancer: towards an ideal strategy].
    Rixe O
    Rev Mal Respir; 2001 Sep; 18(4 Pt 1):365-6. PubMed ID: 11547240
    [No Abstract]   [Full Text] [Related]  

  • 13. The role of radiation, with or without chemotherapy, in the management of NSCLC.
    Chakravarthy A; Johnson D; Choy H
    Oncology (Williston Park); 1999 Oct; 13(10 Suppl 5):93-100. PubMed ID: 10550832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized, multicenter, phase II study of gemcitabine plus cisplatin versus gemcitabine plus carboplatin in patients with advanced non-small cell lung cancer.
    Mazzanti P; Massacesi C; Rocchi MB; Mattioli R; Lippe P; Trivisonne R; Buzzi F; De Signoribus G; Tuveri G; Rossi G; Di Lullo L; Sturba F; Morale D; Catanzani S; Pilone A; Bonsignori M; Battelli T
    Lung Cancer; 2003 Jul; 41(1):81-9. PubMed ID: 12826316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carboplatin and gemcitabine in stage IV non small cell lung cancer: beyond cisplatin in palliative chemotherapy.
    Tassinari D; Fochessati F; Arcangeli V; Panzini I; Ravaioli A; Sartori S
    Lung Cancer; 2003 Jan; 39(1):107-8. PubMed ID: 12499103
    [No Abstract]   [Full Text] [Related]  

  • 16. Amifostine reduces radiochemotherapy-induced toxicities in patients with locally advanced non-small cell lung cancer.
    Antonadou D; Petridis A; Synodinou M; Throuvalas N; Bolanos N; Veslemes M; Sagriotis A
    Semin Oncol; 2003 Dec; 30(6 Suppl 18):2-9. PubMed ID: 14727235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiation recall phenomenon presenting as myositis triggered by carboplatin plus paclitaxel and related literature review.
    Maeng CH; Park JS; Lee SA; Kim DH; Yun DH; Yoo SD; Kim HS; Chon J
    J Cancer Res Ther; 2014; 10(4):1093-7. PubMed ID: 25579560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gemcitabine, cisplatin, and hyperfractionated accelerated radiotherapy for locally advanced non-small cell lung cancer.
    Zwitter M; Kovac V; Smrdel U; Strojan P
    J Thorac Oncol; 2006 Sep; 1(7):662-6. PubMed ID: 17409933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiosensitization with chemotherapeutic agents.
    Caffo O
    Lung Cancer; 2001 Dec; 34 Suppl 4():S81-90. PubMed ID: 11742709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel triplet regimen with paclitaxel, carboplatin and gemcitabine (PACCAGE) as induction chemotherapy for locally advanced unresectable non small cell lung cancer (NSCLC).
    Schallier D; Neyns B; Fontaine C; Steene JV; De Mey J; Meysman M; De Grève J
    Lung Cancer; 2007 May; 56(2):247-54. PubMed ID: 17337086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.